Brief report: Evaluation of polymerized ragweed extracts by intradermal end point titration, RAST inhibition, and parallel line bioassay

Leslie C. Grammer*, Martha A. Shaughnessy, John J. Shaughnessy, Roy Patterson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

We have evaluated six polymerized ragweed extracts on the basis of RAST inhibition, parallel line bioassay, and intradermal end point titration. The results of the parallel line bioassay and intradermal end point titration are highly correlated (r = 0.995, df = 2. p < 0.01). Both intradermal end point titration (r = 0.973, df = 4, p < 0.01) and parallel line bioassay (r = 0.985, df = 2, p < 0.05) are highly correlated with RAST inhibition. We have evaluated the utility of intradermal end point titration as a quantitative assay of relative allergenicity of polymerized extracts. The between assay reproducibility was derived by comparing a reference polymerized ragweed extract against itself. The 99% confidence limits of relative allergenicity were 53% to 188% when four assays were used. This compares favorably to the published 99% confidence limits of the parallel line bioassay 60% to 166% when three assays were used. Intradermal end point titration is highly reproducible, is highly correlated with RAST inhibition or parallel line bioassay, and thus is an appropriate bioassay of allergenic activity.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalThe Journal of allergy and clinical immunology
Volume76
Issue number1
DOIs
StatePublished - Jul 1985

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Brief report: Evaluation of polymerized ragweed extracts by intradermal end point titration, RAST inhibition, and parallel line bioassay'. Together they form a unique fingerprint.

Cite this